PURE Bioscience (OTCMKTS:PURE) is set to announce its earnings results after the market closes on Thursday, December 14th. Analysts expect the company to announce earnings of ($0.02) per share for the quarter.
Shares of PURE Bioscience (OTCMKTS PURE) opened at $0.99 on Tuesday. PURE Bioscience has a 12-month low of $0.75 and a 12-month high of $1.36.
Separately, ValuEngine raised PURE Bioscience from a “sell” rating to a “hold” rating in a research note on Wednesday, November 29th.
PURE Bioscience, Inc is focused on developing and commercializing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The Company’s technology platform is based on stabilized ionic silver and its products contain silver dihydrogen citrate (SDC).
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.